Autism Spectrum Disorder: Classification, diagnosis and therapy
- PMID: 29763648
- DOI: 10.1016/j.pharmthera.2018.05.007
Autism Spectrum Disorder: Classification, diagnosis and therapy
Abstract
Autism Spectrum Disorder (ASD) refers to a group of neurodevelopmental disorders including autism, Asperger's syndrome (AS) and pervasive developmental disorder-not otherwise specified (PDD-NOS). The new diagnostic criteria of ASD focuses on two core domains: social communication impairment and restricted interests/repetitive behaviors. The prevalence of ASD has been steadily increasing over the past two decades, with current estimates reaching up to 1 in 36 children. Hereditary factors, parental history of psychiatric disorders, pre-term births, and fetal exposure to psychotropic drugs or insecticides have all been linked to higher risk of ASD. Several scales such as the Childhood Autism Rating Scale (CARS), The Autism Spectrum Disorder-Observation for Children (ASD-OC), The Developmental, Dimensional, and Diagnostic Interview (3di), are available to aid in better assessing the behaviors and symptoms associated with ASD. Nearly 75% of ASD patients suffer from comorbid psychiatric illnesses or conditions, which may include attention-deficit hyperactivity disorder (ADHD), anxiety, bipolar disorder, depression, Tourette syndrome, and others. Both pharmacological and non-pharmacological interventions are available for ASD. Pharmacological treatments include psychostimulants, atypical antipsychotics, antidepressants, and alpha-2 adrenergic receptor agonists. These medications provide partial symptomatic relief of core symptoms of ASD or manage the symptoms of comorbid conditions. Non-pharmacological interventions, which show promising evidence in improving social interaction and verbal communication of ASD patients, include music therapy, cognitive behavioral therapy and social behavioral therapy. Hormonal therapies with oxytocyin or vasopressin receptor antagonists have also shown some promise in improving core ASD symptoms. The use of vitamins, herbal remedies and nutritional supplements in conjunction with pharmacological and behavioral treatment appear to have some effect in symptomatic improvement in ASD, though additional studies are needed to confirm these benefits. Developing novel disease-modifying therapies may prove to be the ultimate intervention for sustained improvement of symptoms in ASD.
Keywords: Asperger's syndrome; Autism; Cognitive behavioral therapy; Comorbid disorders; Music therapy; Pervasive developmental disorder.
Copyright © 2018 Elsevier Inc. All rights reserved.
Similar articles
-
Implications of comorbid ADHD in ASD interventions and outcome: Results from a naturalistic follow up study from south India.Asian J Psychiatr. 2018 Mar;33:68-73. doi: 10.1016/j.ajp.2018.03.009. Epub 2018 Mar 2. Asian J Psychiatr. 2018. PMID: 29544110
-
The pediatric psychopharmacology of autism spectrum disorder: A systematic review - Part I: The past and the present.Prog Neuropsychopharmacol Biol Psychiatry. 2021 Aug 30;110:110326. doi: 10.1016/j.pnpbp.2021.110326. Epub 2021 Apr 20. Prog Neuropsychopharmacol Biol Psychiatry. 2021. PMID: 33857522
-
Psychopharmacological interventions in autism spectrum disorder.Expert Opin Pharmacother. 2016;17(7):937-52. doi: 10.1517/14656566.2016.1154536. Epub 2016 Mar 7. Expert Opin Pharmacother. 2016. PMID: 26891879 Review.
-
Effects of Yokukansan, a Japanese Kampo Medicine for Symptoms Associated Autism Spectrum Disorder.CNS Neurol Disord Drug Targets. 2016;15(5):551-63. doi: 10.2174/1871527315666160413120541. CNS Neurol Disord Drug Targets. 2016. PMID: 27071791 Review.
-
Mood Stabilizers in Children and Adolescents With Autism Spectrum Disorders.Clin Neuropharmacol. 2015 Sep-Oct;38(5):177-82. doi: 10.1097/WNF.0000000000000096. Clin Neuropharmacol. 2015. PMID: 26366961 Review.
Cited by
-
Mapping neural correlates of biological motion perception in autistic children using high-density diffuse optical tomography.Mol Autism. 2024 Aug 22;15(1):35. doi: 10.1186/s13229-024-00614-4. Mol Autism. 2024. PMID: 39175054
-
Biomimetic nanoparticles with enhanced rapamycin delivery for autism spectrum disorder treatment via autophagy activation and oxidative stress modulation.Theranostics. 2024 Jul 15;14(11):4375-4392. doi: 10.7150/thno.95614. eCollection 2024. Theranostics. 2024. PMID: 39113803 Free PMC article.
-
Effect of Video Modeling With Simulation on Improving Menstrual Hygiene Skills for Adolescents With Autism Spectrum Disorder.Cureus. 2024 Jun 21;16(6):e62847. doi: 10.7759/cureus.62847. eCollection 2024 Jun. Cureus. 2024. PMID: 39040730 Free PMC article.
-
Enhancing social behavior in an autism spectrum disorder mouse model: investigating the underlying mechanisms of Lactiplantibacillus plantarum intervention.Gut Microbes. 2024 Jan-Dec;16(1):2359501. doi: 10.1080/19490976.2024.2359501. Epub 2024 Jun 6. Gut Microbes. 2024. PMID: 38841895 Free PMC article.
-
Neuromodulation and the Gut-Brain Axis: Therapeutic Mechanisms and Implications for Gastrointestinal and Neurological Disorders.Pathophysiology. 2024 May 17;31(2):244-268. doi: 10.3390/pathophysiology31020019. Pathophysiology. 2024. PMID: 38804299 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous